{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:30Z","timestamp":1791231570229,"version":"4.1.0"},"reference-count":96,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2022.11463","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:48:33Z","timestamp":1656071313000},"source":"Crossref","is-referenced-by-count":17,"title":["Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)"],"prefix":"10.3892","volume":"24","author":[{"given":"Laura","family":"Gnesotto","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padova, I\u201135128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Mioso","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padova, I\u201135128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padova, I\u201135128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"key20220729125925_b1-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3748\/wjg.v27.i10.908","article-title":"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective","volume":"27","author":"Dom\u00e8nech","year":"2021","journal-title":"World J Gastroenterol"},{"key":"key20220729125925_b2-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/1346-8138.14471","article-title":"Clinical and immunological effects of adsorptive myeloid lineage leukocyte apheresis in patients with immune disorders","volume":"45","author":"Kanekura","year":"2018","journal-title":"J Dermatol"},{"key":"key20220729125925_b3-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1744-9987.2006.00369.x","article-title":"Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: Evidence that GCAP removes Mac-1-expressing neutrophils","volume":"10","author":"Kanekura","year":"2006","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b4-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4291\/wjgp.v11.i3.43","article-title":"Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future","volume":"11","author":"Chen","year":"2020","journal-title":"World J Gastrointest Pathophysiol"},{"key":"key20220729125925_b5-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.autrev.2008.09.001","article-title":"Granulocyte\/monocyte apheresis as immunotherapic tool: Cellular adsorption and immune modulation","volume":"8","author":"Cuadrado","year":"2009","journal-title":"Autoimmun Rev"},{"key":"key20220729125925_b6-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04279.x","article-title":"The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: A concise review","volume":"163","author":"Hanai","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"key20220729125925_b7-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s10620-006-9560-z","article-title":"Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: Modified by selective granulocyte and monocyte adsorption apheresis","volume":"52","author":"Yokoyama","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key20220729125925_b8-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/1744-9987.12466","article-title":"Effect of cellulose acetate beads on interleukin-23 release","volume":"20","author":"Nishise","year":"2016","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b9-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.gastrohep.2018.04.007","article-title":"Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view","volume":"41","author":"Rodr\u00edguez-Lago","year":"2018","journal-title":"Gastroenterol Hepatol"},{"issue":"41","key":"key20220729125925_b10-ETM-24-2-11463","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-41","article-title":"Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone","volume":"13","author":"Tominaga","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"key20220729125925_b11-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.dld.2007.03.007","article-title":"Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?","volume":"39","author":"Pan\u00e9s","year":"2007","journal-title":"Dig Liver Dis"},{"key":"key20220729125925_b12-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000321911","article-title":"Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants","volume":"84","author":"Yoshino","year":"2011","journal-title":"Digestion"},{"key":"key20220729125925_b13-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"265","DOI":"10.23736\/S0392-0488.18.05841-8","article-title":"Neutrophilic dermatoses: A broad spectrum of disease","volume":"153","author":"Filosa","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"key20220729125925_b14-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","article-title":"Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Beh\u00e7et disease","volume":"79","author":"Nelson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b15-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"61","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"key20220729125925_b16-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: Current concepts of pathogenesis","volume":"64 (Suppl 2)","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key20220729125925_b17-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/0961203319854139","article-title":"A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus","volume":"28","author":"Shindo","year":"2019","journal-title":"Lupus"},{"key":"key20220729125925_b18-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: A review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20220729125925_b19-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20220729125925_b20-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1067\/s0190-9622(03)00795-3","article-title":"Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis","volume":"49","author":"Kanekura","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b21-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1684\/ejd.2017.3174","article-title":"Genetic background and therapeutic response in generalized pustular psoriasis patients treated with granulocyte and monocyte adsorption apheresis","volume":"28","author":"Ohnishi","year":"2018","journal-title":"Eur J Dermatol"},{"key":"key20220729125925_b22-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1744-9987.12357","article-title":"Safety and tolerability of nafamostat mesilate and heparin as anticoagulants in leukocytapheresis for ulcerative colitis: Post Hoc analysis of a large-scale, prospective, observational study","volume":"20","author":"Sawada","year":"2016","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b23-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1346-8138.2011.01279.x","article-title":"Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis","volume":"38","author":"Shukuya","year":"2011","journal-title":"J Dermatol"},{"key":"key20220729125925_b24-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jdermsci.2014.02.006","article-title":"The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants","volume":"74","author":"Sugiura","year":"2014","journal-title":"J Dermatol Sci"},{"key":"key20220729125925_b25-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1744-9987.2012.01109.x","article-title":"Successful treatment of three cases of generalized pustular psoriasis with granulocyte and monocyte adsorption apheresis","volume":"16","author":"Suzuki","year":"2012","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b26-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/1346-8138.15569","article-title":"Intensive granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis","volume":"47","author":"Mizutani","year":"2020","journal-title":"J Dermatol"},{"key":"key20220729125925_b27-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1744-9987.12596","article-title":"Generalized pustular psoriasis with IL-36 Receptor antagonist mutation successfully treated with granulocyte and monocyte adsorption apheresis accompanied by reduced serum IL-6 level","volume":"22","author":"Fujii","year":"2018","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b28-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1744-9987.12113","article-title":"Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy","volume":"17","author":"Sakanoue","year":"2013","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b29-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jaad.2012.09.037","article-title":"Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis","volume":"68","author":"Ikeda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b30-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/1744-9987.12816","article-title":"Generalized pustular psoriasis with CARD14 Variant c.526G>C (p.Asp176His) successfully treated with granulocyte and monocyte adsorption apheresis","volume":"23","author":"Fujii","year":"2019","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b31-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/bjd.15509","article-title":"Granulocyte and monocyte apheresis can control juvenile generalized pustular psoriasis with mutation of IL36RN","volume":"177","author":"Koike","year":"2017","journal-title":"Br J Dermatol"},{"key":"key20220729125925_b32-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2340\/00015555-1463","article-title":"Combination therapy of infliximab and granulocyte\/monocyte adsorption apheresis for refractory pustular psoriasis with psoriatic arthritis","volume":"93","author":"Fujisawa","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"key20220729125925_b33-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000380876","article-title":"A case of old age-onset generalized pustular psoriasis with a deficiency of IL-36RN (DITRA) treated by granulocyte and monocyte apheresis","volume":"7","author":"Tominaga","year":"2015","journal-title":"Case Rep Dermatol"},{"key":"key20220729125925_b34-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1744-9987.2011.00961.x","article-title":"Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis","volume":"15","author":"Fujisawa","year":"2011","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b35-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/1744-9987.12342","article-title":"Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis: Therapeutic outcomes in three refractory patients","volume":"19","author":"Fujisawa","year":"2015","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b36-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1744-9987.2012.01067.x","article-title":"Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis","volume":"16","author":"Furusawa","year":"2012","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b37-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/1346-8138.12501","article-title":"Case of generalized pustular psoriasis with end-stage renal disease successfully treated with granulocyte monocyte apheresis in combination with hemodialysis","volume":"41","author":"Mabuchi","year":"2014","journal-title":"J Dermatol"},{"key":"key20220729125925_b38-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1744-9987.2007.00536.x","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis","volume":"12","author":"Seishima","year":"2008","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b39-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/jdv.12383","article-title":"Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis","volume":"28","author":"Sugiura","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"81","key":"key20220729125925_b40-ETM-24-2-11463","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0213-x","article-title":"Pyoderma gangrenosum","volume":"6","author":"Maverakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"key20220729125925_b41-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: A comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"key20220729125925_b42-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An update on pathophysiology, diagnosis and treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"key20220729125925_b43-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/iwj.12684","article-title":"Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis","volume":"14","author":"Russo","year":"2017","journal-title":"Int Wound J"},{"key":"key20220729125925_b44-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/1744-9987.13720","article-title":"Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum","volume":"26","author":"Higashi","year":"2022","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b45-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1684\/ejd.2011.1461","article-title":"Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis","volume":"21","author":"Ikeda","year":"2011","journal-title":"Eur J Dermatol"},{"key":"key20220729125925_b46-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/j.1572-0241.2003.07657.x","article-title":"Treatment of pyoderma gangrenosum associated with Crohn's disease","volume":"98","author":"Ohmori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"key20220729125925_b47-ETM-24-2-11463","first-page":"1099","article-title":"A case of successful treatment with granulocytapheresis (GCAP) for pyoderma gangrenosum complicating ulcerative colitis","volume":"58","author":"Ishikawa","year":"2004","journal-title":"Jap J Clin Dermatol"},{"key":"key20220729125925_b48-ETM-24-2-11463","first-page":"263","article-title":"Four Cases of pyoderma gangrenosum associated with ulcerative colitis","volume":"59","author":"Yoneda","year":"2005","journal-title":"Jap J Clin Dermatol"},{"key":"key20220729125925_b49-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/01.mib.0000172558.39767.b7","article-title":"Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: A case report","volume":"11","author":"Yanaru-Fujisawa","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"key20220729125925_b50-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1744-9987.2007.00424.x","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum","volume":"11","author":"Seishima","year":"2007","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b51-ETM-24-2-11463","first-page":"29","article-title":"A case of Pyoderma Gangrenosum successfully treated by granulocytapheresis and steroid therapy","volume":"30","author":"Fujino","year":"2008","journal-title":"Tokushima J Med"},{"key":"key20220729125925_b52-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/ajg.2009.271","article-title":"Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis","volume":"104","author":"Kawakami","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key20220729125925_b53-ETM-24-2-11463","first-page":"585","volume":"52","author":"Doi","year":"2010","journal-title":"Rinsho Derma"},{"key":"key20220729125925_b54-ETM-24-2-11463","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2336\/nishinihonhifu.73.474","article-title":"A case of Pyoderma Gangrenosum with Ulcerative Colitis successfully treated with Granulocytapheresis, Skin grafting and Steroid therapy","volume":"73","author":"Kobayashi","year":"2011","journal-title":"Nishi Nihon Hifuka"},{"key":"key20220729125925_b55-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2169\/internalmedicine.55.5422","article-title":"Pyoderma gangrenosum with ulcerative colitis successfully treated by the combination of granulocyte and monocyte adsorption apheresis and corticosteroids","volume":"55","author":"Ohno","year":"2016","journal-title":"Intern Med"},{"key":"key20220729125925_b56-ETM-24-2-11463","first-page":"150","article-title":"A case of successful treatment with granulocytapheresis for pyoderma gangrenosum complicating ulcerative colitis","volume":"16","author":"Okada","year":"2017","journal-title":"Skin Research"},{"key":"key20220729125925_b57-ETM-24-2-11463","doi-asserted-by":"crossref","first-page":"130","DOI":"10.11641\/pde.90.1_130","article-title":"Ulcerative colitis accompanied by pyoderma gangrenosum successfully treated with granulocyte monocyte apheresis: A case report","volume":"90","author":"Yamashita","year":"2017","journal-title":"Prog Dig Endosc"},{"key":"key20220729125925_b58-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.12998\/wjcc.v8.i11.2092","article-title":"Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status","volume":"8","author":"Tominaga","year":"2020","journal-title":"World J Clin Cases"},{"key":"key20220729125925_b59-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jca.21821","article-title":"Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis","volume":"35","author":"Shibuya","year":"2020","journal-title":"J Clin Apher"},{"key":"key20220729125925_b60-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1744-9987.2005.00284.x","article-title":"Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis","volume":"9","author":"Kanekura","year":"2005","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b61-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1067\/mjd.2002.120597","article-title":"Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum","volume":"47","author":"Kanekura","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b62-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s12328-021-01460-0","article-title":"Pyoderma gangrenosum with primary sclerosing cholangitis-associated colitis successfully treated with concomitant granulocyte and monocyte adsorption apheresis with corticosteroids","volume":"14","author":"Kawai","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"key20220729125925_b63-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jdermsci.2020.03.003","article-title":"Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism","volume":"98","author":"Murakami","year":"2020","journal-title":"J Dermatol Sci"},{"key":"key20220729125925_b64-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b65-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/1744-9987.12210","article-title":"Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis","volume":"18","author":"Fujisawa","year":"2014","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b66-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/1346-8138.14717","article-title":"Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis","volume":"46","author":"Kawakami","year":"2019","journal-title":"J Dermatol"},{"key":"key20220729125925_b67-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/s0190-9622(03)02474-5","article-title":"Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis","volume":"50","author":"Kanekura","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b68-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clindermatol.2017.06.004","article-title":"Beh\u00e7et disease: New aspects","volume":"35","author":"Bulur","year":"2017","journal-title":"Clin Dermatol"},{"issue":"665","key":"key20220729125925_b69-ETM-24-2-11463","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet's Disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front Immunol"},{"key":"key20220729125925_b70-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","article-title":"Mucocutaneous lesions of Behcet's disease","volume":"48","author":"Alpsoy","year":"2007","journal-title":"Yonsei Med J"},{"key":"key20220729125925_b71-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/1346-8138.12296","article-title":"Granulocyte and monocyte adsorption apheresis for Beh\u00e7et's disease in a pregnant woman","volume":"40","author":"Higashi","year":"2013","journal-title":"J Dermatol"},{"key":"key20220729125925_b72-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jaad.2003.12.023","article-title":"Treatment of Beh\u00e7et's disease with granulocyte and monocyte adsorption apheresis","volume":"51 (2 Suppl)","author":"Kanekura","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b73-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet Syndrome: A review and update","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermosifiliogr"},{"issue":"34","key":"key20220729125925_b74-ETM-24-2-11463","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"key20220729125925_b75-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000475878","article-title":"Sweet's syndrome successfully treated with granulocyte and monocyte adsorption apheresis","volume":"9","author":"Fujii","year":"2017","journal-title":"Case Rep Dermatol"},{"key":"key20220729125925_b76-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"key20220729125925_b77-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"key20220729125925_b78-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2230.2004.01502.x","article-title":"Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis","volume":"29","author":"Kanekura","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"key20220729125925_b79-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/1744-9987.12653","article-title":"Granulocyte\/Monocyte adsorption apheresis as a novel therapeutic approach in the treatment of an impetigo herpetiformis case","volume":"22","author":"Iwasaki","year":"2018","journal-title":"Ther Apher Dial"},{"issue":"5801280","key":"key20220729125925_b80-ETM-24-2-11463","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5801280","article-title":"Impetigo herpetiformis: Review of pathogenesis, complication, and treatment","volume":"2018","author":"Namazi","year":"2018","journal-title":"Dermatol Res Pract"},{"key":"key20220729125925_b81-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1111\/1346-8138.15241","article-title":"Impetigo herpetiformis with a CARD14 Thr79Ile variant successfully treated with granulocyte and monocyte adsorption apheresis","volume":"47","author":"Fujii","year":"2020","journal-title":"J Dermatol"},{"key":"key20220729125925_b82-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2340\/00015555-2527","article-title":"Impetigo herpetiformis complicated with intrauterine growth restriction treated successfully with granulocyte and monocyte apheresis","volume":"97","author":"Saito-Sasaki","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"key20220729125925_b83-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"key20220729125925_b84-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaad.2008.02.047","article-title":"Reiter's syndrome: the classic triad and more","volume":"59","author":"Wu","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b85-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2230.2011.04181.x","article-title":"Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease","volume":"37","author":"Yoshifuku","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"key20220729125925_b86-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key20220729125925_b87-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH Syndromes: Pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"key20220729125925_b88-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/1346-8138.15946","article-title":"Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis","volume":"48","author":"Hatanaka","year":"2021","journal-title":"J Dermatol"},{"key":"key20220729125925_b89-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2340\/00015555-2507","article-title":"Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome treated with granulocyte and monocyte adsorption apheresis","volume":"97","author":"Mizutani","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"key20220729125925_b90-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-4362.1988.tb02353.x","article-title":"Possible pathogenetic mechanisms in allergic cutaneous vasculitis","volume":"27","author":"Tosca","year":"1988","journal-title":"Int J Dermatol"},{"key":"key20220729125925_b91-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"key20220729125925_b92-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"key20220729125925_b93-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1744-9987.2006.00335.x","article-title":"Granulocyte and monocyte adsorption apheresis for cutaneous allergic vasculitis","volume":"10","author":"Kanekura","year":"2006","journal-title":"Ther Apher Dial"},{"key":"key20220729125925_b94-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"key20220729125925_b95-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: Epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent Clin North Am"},{"key":"key20220729125925_b96-ETM-24-2-11463","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000075053","article-title":"Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis","volume":"208","author":"Kanekura","year":"2004","journal-title":"Dermatology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:59:42Z","timestamp":1659088782000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2022.11463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":96,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,24]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2022.11463","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"536"}}